PILA PHARMA AB
Clinical stage biotech developing an oral obesity and diabetes treatment.
Overview
- 1–4
- Employees
- 750–999K SEK
- Revenue
- 2014
- Founded
Description
PILA PHARMA is a clinical stage biotechnology company focused on innovative drug development. The organization is pioneering the development of XEN-D0501, an oral TRPV1-antagonist. This drug candidate is being positioned as a potential first-in-class treatment for serious conditions like obesity and...